Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
121.00    -5.00 (-3.97%)
Bid:
121.00
Ask:
129.00
Spread: 8.00 (6.612%)
Market Cap: £192.78m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Trading update and COVID-19 update

3 Apr 2020 07:00

RNS Number : 6624I
Redcentric PLC
03 April 2020
 

Redcentric plc

("Redcentric" or the "Company")

 

Trading update and COVID-19 update

Redcentric plc (AIM: RCN), a leading UK IT managed services provider, is today issuing a trading update for the year ended 31 March 2020 along with an update in relation to the current impact of and measures taken by the Company in response to COVID-19.

 

Trading update for the year ended 31 March 2020

The Board is pleased to announce that the Company's trading performance for the year ended 31 March 2020 is expected to be in line with its expectations.

Net debt at 31 March 2020 was £13.5m, including £0.4m of share buy backs in the second half of the financial year.

The Company expects to report its full year results for the year ended 31 March 2020 on 25 June 2020.

 

COVID-19 update

Overview

The Company's overriding concern is the health, safety and wellbeing of its employees, customers and business partners. We are complying with all relevant government recommendations both in the UK and India and the vast majority of our staff have been working remotely since 17 March 2020. We pride ourselves in delivering excellent customer service and this has not been affected following these changes. This has been made possible by our employees' flexible and positive attitude and we thank them for their support during this time.

The duration and extent of the economic consequences of the pandemic are currently unknown and this makes predicting future demand for the Company's offerings difficult. However, the Board believes that the Company is well placed to withstand the current challenges. In particular:

· Our strategy of focusing on our network and platform infrastructure has put us in a good position to meet the increased demand for flexible and remote co-working.

· Our recent focus on the Public sector networks and, in particular, the Health and Social Care Networks (HSCN) has provided a large number of new logo customers where we have significant cross sell opportunities.

· 90% of our revenues are recurring in nature and over half of our non-recurring revenue has historically been derived from the Health sector.

· The business is operating profitably with pre IFRS16 EBITDA margins expected to increase.

· The business is cash generative and the recent network and platform upgrades mean that we have modern, scalable platforms which will require lower levels of capital expenditure over the medium term.

· We have low levels of borrowing with pre IFRS16 net debt currently less than one times annualised pre IFRS16 EBITDA. As at 31 March 2020, gross cash was £3.7m with a further £8.0m available from undrawn bank credit facilities.

Sales

In the second half of March 2020 we saw a material increase in sales opportunities as a result of the COVID-19 pandemic. Demand has been particularly strong for increased bandwidth and, in particular, for our secure remote access product. As a result, the volume of new recurring revenue contracts signed in March was materially above that seen in previous years.

We are currently working on closing out the remaining leads generated in March and as a result we expect April new sales volumes to be as anticipated for this time of the year. 

Looking further forward, we anticipate a reduction in sales to new customers and a slowdown in major change projects from existing customers until such time as the COVID-19 crisis is averted. We also anticipate that some of our customers may come under pressure as a result of the COVID-19 pandemic and this may lead to delayed customer receipts and increased business failures. 

Offsetting this, we expect a lower level of normalised cancellations and renewal churn in the same period.

Deliveries

Deliveries in the last quarter of FY20 have been strong as a result of significant additional temporary resource being employed to roll out the HSCN contracts. Whilst these networks have been slower to roll out than anticipated, circa 75% of the contracts are now implemented with the remainder expected to be live by the end of June 2020. 

The additional sales orders signed in March 2020 and those anticipated for April 2020 are all products that are very quick to install and require minimal third-party intervention.

With respect to the remaining unfulfilled orders, installations requiring on-site engineers are likely to be delayed and hence revenues will be delayed. At this time, it is impossible to know how long this situation is likely to continue.

Share buyback and dividend

The Board has taken the decision to temporarily halt the share buyback programme until such time as the outlook becomes more certain.

In addition, although the Board will continue to monitor the effects of Covid-19, in light of the current situation it is highly unlikely that a final dividend for the year will be recommended by the Board.

 

Enquiries:

Redcentric plc +44 (0)800 983 2522

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

finnCap Ltd - Nomad and Broker +44 (0)20 7220 0500

Marc Milmo/ Simon Hicks (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUPUAACUPUGBP
Date   Source Headline
19th Jun 20267:00 amRNSProposed £90 million Tender Offer & Notice of GM
1st Jun 20267:01 amRNSAppointment of Chief Financial Officer
1st Jun 20267:00 amRNSTrading Update
13th May 20261:25 pmRNSCapital Reduction Result of General Meeting
12th May 20267:00 amRNSExercise of Options
1st May 20267:00 amRNSCompletion of Sale of Redcentric Data Centres Ltd
24th Apr 20267:00 amRNSProposed Capital Reduction & Notice of GM
14th Apr 20267:00 amRNSExercise of Options
8th Apr 202612:55 pmRNSDirector/PDMR Shareholdings
19th Mar 20263:26 pmRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
23rd Feb 20261:00 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSExercise of Options
9th Jan 202610:09 amRNSExercise of Options
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 20257:00 amRNSExercise of Options
31st Dec 20257:00 amRNSExercise of Options
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
22nd Dec 202511:46 amRNSGrant of Options
22nd Dec 202511:46 amRNSGrant of Options
12th Dec 20253:49 pmRNSDirector/PDMR Shareholdings
11th Dec 20257:00 amRNSExercise of Options
10th Dec 20257:00 amRNSHalf Year Results
4th Dec 20257:00 amRNS-RPresentation via Investor Meet Company
14th Nov 20257:00 amRNSExercise of Options
6th Nov 20258:00 amRNSSAYE Share Option Scheme
5th Nov 20257:00 amRNSH1 Trading Update and Notice of Results
27th Oct 20254:36 pmRNSHolding(s) in Company
24th Oct 20257:00 amRNSExercise of Options
23rd Oct 20257:00 amRNSDisposal of Redcentric Data Centres Limited
20th Oct 20254:48 pmRNSResult of AGM
17th Oct 202512:40 pmRNSExercise of Options
13th Oct 20259:40 amRNSExercise of Options
3rd Oct 20257:00 amRNSExercise of Options
25th Sep 20257:00 amRNSPublication of Annual Report and Notice of AGM
24th Sep 20257:00 amRNSFinal Results
2nd Sep 20257:00 amRNSNotice of Final Results
22nd Aug 20251:13 pmRNSResponse to recent press speculation
19th Aug 20257:00 amRNSAppointment of Chief Financial Officer
1st Aug 20257:00 amRNSExercise of Options
7th Jul 20257:00 amRNSExercise of Options
23rd Jun 20257:00 amRNSExercise of Options
17th Jun 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.